[Dear Doctor, when two drugs have been shown to have equal efficacy, it becomes important for you to differentiate between them on the basis of side effects and drug interactions] part 3
The Kidney core organ in hypertension and past its prime in most hypertensive patients
Type of Work:
Print or label
Registration Number / Date:
TX0000789065 / 1981-09-15
Date of Publication:
February 1, 1980
Date of Creation:
1980
Title:
The Kidney core organ in hypertension and past its prime in most hypertensive patients.
Basis of Claim:
New Matter: "textual materials and artwork."
Previous Registration:
Prev. reg. 1979, TX 273-365.
Description:
Folder.
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Notes:
Advertisement for "Diulo (metolazone)"
Names:
Searle Pharmaceuticals, Inc.
|
|
The New wave in cardiology
Type of Work:
Print or label
Registration Number / Date:
TX0000793798 / 1981-11-02
Date of Publication:
October 14, 1981
Date of Creation:
1981
Title:
The New wave in cardiology.
Basis of Claim:
New Matter: "textual material and artwork."
Previous Registration:
Prev. reg. 1981, TX 767-863 & TX 767-864.
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc.
Calan (verapamil HCI) the prototype calcium antagonist is now available and that's exciting news for nurses in the CCU and emergency department
Type of Work:
Print or label
Registration Number / Date:
TX0000793799 / 1981-11-02
Date of Publication:
August 26, 1981
Date of Creation:
1981
Title:
Calan (verapamil HCI) the prototype calcium antagonist is now available and that's exciting news for nurses in the CCU and emergency department.
Basis of Claim:
New Matter: "textual material and artwork."
Previous Registration:
Prev. reg. 1981, TX 767-863.
Variant title:
Calan (verapamil HCI) the prototype calcium antagonist is now available and that's exciting news for nurses
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc.
Calan (verapamil HCI), the prototype calcium antagonist
Type of Work:
Print or label
Registration Number / Date:
TX0000794176 / 1981-11-02
Date of Publication:
September 16, 1981
Date of Creation:
1981
Title:
Calan (verapamil HCI), the prototype calcium antagonist : the new wave in cardiology.
Basis of Claim:
New Matter: "textual material & artwork."
Previous Registration:
Product data prev. reg. 1981, TX 767-864.
Description:
Folder.
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc. (86 documents)
example document: Are you ready? New Once disposable diaphragm with contraceptive gel
example document: Are you ready? New Once disposable diaphragm with contraceptive gel
After the wound is closed
Type of Work:
Print or label
Registration Number / Date:
TX0000796486 / 1981-11-02
Date of Publication:
July 25, 1981
Date of Creation:
1981
Title:
After the wound is closed.
Description:
1 v.
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc.
A Clinical profile
Type of Work:
Print or label
Registration Number / Date:
TX0000797304 / 1981-11-02
Date of Publication:
September 11, 1981
Date of Creation:
1981
Title:
A Clinical profile : Calan (verapamil HCl)
Basis of Claim:
New Matter: "textual materials."
Previous Registration:
Prev. reg. 1981, TX 767-864.
Variant title:
A Clinical profile : Calan (verapamil HCl)
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc.
Aminophyllin (aminophylline) therapy can help your asthmatic patients play hard, live well, sleep soundly
Type of Work:
Print or label
Registration Number / Date:
TX0000800434 / 1981-11-06
Date of Publication:
December 5, 1979
Date of Creation:
1979
Title:
Aminophyllin (aminophylline) therapy can help your asthmatic patients play hard, live well, sleep soundly.
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc.
Aminophyllin (aminophylline) special offer limited time save 9% on selected products and sizes
Type of Work:
Print or label
Registration Number / Date:
TX0000800435 / 1981-11-06
Date of Publication:
October 15, 1979
Date of Creation:
1979
Title:
Aminophyllin (aminophylline) special offer limited time save 9% on selected products and sizes.
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc.
Dramamine (dimenhydrinate) exclusive, now through December 31, 1979
Type of Work:
Print or label
Registration Number / Date:
TX0000800695 / 1981-11-02
Date of Publication:
November 30, 1979
Date of Creation:
1979
Title:
Dramamine (dimenhydrinate) exclusive, now through December 31, 1979.
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc.
From Searle--"an important therapeutic advance" against anaerobic infections
Type of Work:
Print or label
Registration Number / Date:
TX0000803829 / 1981-11-20
Date of Publication:
January 12, 1981
Date of Creation:
1980
Date in Notice:
notice:
Title:
From Searle--"an important therapeutic advance" against anaerobic infections.
Basis of Claim:
New Matter: "textual materials and artwork."
Previous Registration:
Prev. reg. 1981, TX 774-160.
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc.
Searle announces Flagyl I.V. (metronidazole HCl) "an important therapeutic advance" against anaerobic infections
Type of Work:
Print or label
Registration Number / Date:
TX0000803830 / 1981-11-20
Date of Publication:
January 12, 1981
Date of Creation:
1980
Date in Notice:
notice:
Title:
Searle announces Flagyl I.V. (metronidazole HCl) "an important therapeutic advance" against anaerobic infections.
Basis of Claim:
New Matter: "textual materials and artwork."
Previous Registration:
Prev. reg. TX 774-160.
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc.
Because physician demand is growing
Type of Work:
Print or label
Registration Number / Date:
TX0000803831 / 1981-11-20
Date of Publication:
June 8, 1981
Date of Creation:
1981
Title:
Because physician demand is growing.
Basis of Claim:
New Matter: "textual materials & artwork."
Previous Registration:
Prev. reg. TX 774-160.
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc.
Building on initial success
Type of Work:
Print or label
Registration Number / Date:
TX0000803846 / 1981-11-20
Date of Publication:
June 8, 1981
Date of Creation:
1981
Title:
Building on initial success : new, ready to use Flagyl I.V. RTU (metronidazole)
Basis of Claim:
New Matter: "textual materials."
Previous Registration:
Prev. reg. 1981, TX 774-160. Preexisting material: artwork.
Variant title:
Building on initial success : new, ready to use Flagyl I.V. RTU (metronidazole)
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc.
Update on aminophyllin (aminophylline)
Type of Work:
Print or label
Registration Number / Date:
TX0000804147 / 1981-11-06
Date of Publication:
July 23, 1979
Date of Creation:
1979
Title:
Update on aminophyllin (aminophylline) : a drug of choice for chronic asthma therapy at a lower cost than other major brands.
Basis of Claim:
New Matter: "textual materials and artwork."
Previous Registration:
Prev. reg. 1979, TX 321-195.
Variant title:
Update on aminophyllin (aminophylline) : a drug of choice for chronic asthma therapy
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc.
Detailed product information for the Cu-7 intrauterine copper contraceptive
Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0000827874 / 1981-11-06
Date of Publication:
July 9, 1979
Date of Creation:
1979
Date in Notice:
notice: 1978
Title:
Detailed product information for the Cu-7 intrauterine copper contraceptive.
Edition:
Rev., Dec. 1978.
Basis of Claim:
New Matter: "textual materials."
Previous Registration:
Prev. reg. 1979, TX 321-194.
Copyright Note:
C.O. correspondence.
Description:
12 p.
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Copyright Notice:
notice: G. D. Searle & Company
Authorship on Application:
Searle Pharmaceuticals, Inc., employer for hire.
Names:
Searle Pharmaceuticals, Inc.
G.D. Searle & Company (31 documents)
example document: Ten questions your patients may ask about the new low-calorie sweetener, NutraSweet
G.D. Searle & Company (31 documents)
example document: Ten questions your patients may ask about the new low-calorie sweetener, NutraSweet
|
|
Rush, new from Searle, fresh taste, just arrived!
Type of Work:
Print or label
Registration Number / Date:
TX0000827875 / 1981-11-06
Date of Publication:
August 20, 1979
Date of Creation:
1979
Title:
Rush, new from Searle, fresh taste, just arrived!
Copyright Note:
C.O. correspondence.
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc.
Contemporary woman
Type of Work:
Print or label
Registration Number / Date:
TX0000827876 / 1981-11-06
Date of Publication:
October 1, 1979
Date of Creation:
1979
Title:
Contemporary woman.
Copyright Note:
C.O. correspondence.
Series:
Consider the contraceptive
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc. (86 documents)
example document: Instructions for reconstituting Flagyl I.V. (metronidazole Hcl)
example document: Instructions for reconstituting Flagyl I.V. (metronidazole Hcl)
Smoker
Type of Work:
Print or label
Registration Number / Date:
TX0000827877 / 1981-11-06
Date of Publication:
July 9, 1979
Date of Creation:
1979
Title:
Smoker.
Copyright Note:
C.O. correspondence.
Series:
Consider the contraceptive
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc.
New, from Searle, Norpace (disopyramide phosphate) in 1000 capsule size
Type of Work:
Print or label
Registration Number / Date:
TX0000844730 / 1981-11-09
Date of Publication:
October 12, 1979
Date of Creation:
1979
Title:
New, from Searle, Norpace (disopyramide phosphate) in 1000 capsule size.
Copyright Note:
C.O. correspondence.
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc.
Recent literature implicates quinidine in raising serum digoxin levels
Type of Work:
Print or label
Registration Number / Date:
TX0000844731 / 1981-11-09
Date of Publication:
January 1, 1980
Date of Creation:
1979
Date in Notice:
notice: 1979
Title:
Recent literature implicates quinidine in raising serum digoxin levels.
Basis of Claim:
New Matter: "textual materials."
Previous Registration:
Prev. reg. 1979, TX 261-464.
Copyright Note:
C.O. correspondence.
Series:
Antiarrhythmia bull. ; no. 1
Other Title:
Antiarrhythmia bull. ; no. 1
Norpace (disopyramide phosphate): a logical therapeutic choice
Norpace (disopyramide phosphate): a logical therapeutic choice
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Notes:
Includes Norpace (disopyramide phosphate): a logical therapeutic choice.
Names:
Searle Pharmaceuticals, Inc.
[Dear Doctor, when two drugs have been shown to have equal efficacy, it becomes important for you to differentiate between them on the basis of side effects and drug interactions]
Type of Work:
Print or label
Registration Number / Date:
TX0000844732 / 1981-11-09
Date of Publication:
November 15, 1980
Date of Creation:
1980
Title:
[Dear Doctor, when two drugs have been shown to have equal efficacy, it becomes important for you to differentiate between them on the basis of side effects and drug interactions]
Basis of Claim:
New Matter: "textual materials."
Previous Registration:
Product data prev. reg. 1979, TX 261-464.
Copyright Note:
C.O. correspondence.
Variant title:
Dear Doctor, when two drugs have been shown to have equal efficacy, it becomes important for you to differentiate
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Notes:
Title from first line of text.
Names:
Searle Pharmaceuticals, Inc.
Fast, accurate serum-level monitoring for Norpace (disopyramide phosphate)
Type of Work:
Print or label
Registration Number / Date:
TX0000844733 / 1981-11-09
Date of Publication:
October 1, 1980
Date of Creation:
1980
Title:
Fast, accurate serum-level monitoring for Norpace (disopyramide phosphate)
Basis of Claim:
New Matter: "textual material & artwork."
Previous Registration:
Product data prev. reg. 1979, TX 261-464.
Copyright Note:
C.O. correspondence.
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc.
A Way out of the quinidine/digoxin quandry
Type of Work:
Print or label
Registration Number / Date:
TX0000844734 / 1981-11-09
Date of Publication:
May 5, 1980
Date of Creation:
1980
Title:
A Way out of the quinidine/digoxin quandry.
Basis of Claim:
New Matter: "textual materials & artwork."
Previous Registration:
Product data prev. reg. 1979, TX 261-464.
Copyright Note:
C.O. correspondence.
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc.
A Practical guide to Norpace (disopyramide phosphate) patient selection and management
Type of Work:
Print or label
Registration Number / Date:
TX0000844735 / 1981-11-09
Date of Publication:
July 28, 1980
Date of Creation:
1980
Title:
A Practical guide to Norpace (disopyramide phosphate) patient selection and management.
Basis of Claim:
New Matter: "textual materials & artwork."
Previous Registration:
Product data prev. reg. 1979, TX 261-464.
Copyright Note:
C.O. correspondence.
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc.
Now, because your time is valuable, introducing Norpace (disopyramide phosphate) unit-dose packaging
Type of Work:
Print or label
Registration Number / Date:
TX0000844736 / 1981-11-09
Date of Publication:
January 9, 1980
Date of Creation:
1980
Title:
Now, because your time is valuable, introducing Norpace (disopyramide phosphate) unit-dose packaging.
Basis of Claim:
New Matter: "textual material & artwork."
Previous Registration:
Product data prev. reg. 1979, TX 261-464.
Copyright Note:
C.O. correspondence.
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc.
What you should expect from an antiarrhythmatic besides efficacy and safety?
Type of Work:
Print or label
Registration Number / Date:
TX0000844737 / 1981-11-09
Date of Publication:
February 11, 1980
Date of Creation:
1980
Title:
What you should expect from an antiarrhythmatic besides efficacy and safety?
Basis of Claim:
New Matter: "textual material & artwork."
Previous Registration:
Product data prev. reg. 1979, TX 261-464.
Copyright Note:
C.O. correspondence.
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc.
Diagnose and treat
Type of Work:
Print or label
Registration Number / Date:
TX0000844738 / 1981-11-09
Date of Publication:
June 2, 1980
Date of Creation:
1980
Title:
Diagnose and treat : a clinical challenge for the physician whose practice includes patients with cardiac arrhythmias.
Basis of Claim:
New Matter: "textual material & artwork."
Previous Registration:
Product data prev. reg. 1979, TX 261-464.
Copyright Note:
C.O. correspondence.
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc.
In specific ventricular arrhythmias, Norpace (disopyramide phosphate), a logical choice for primary-care medicine
Type of Work:
Print or label
Registration Number / Date:
TX0000844739 / 1981-11-09
Date of Publication:
September 10, 1979
Date of Creation:
1979
Title:
In specific ventricular arrhythmias, Norpace (disopyramide phosphate), a logical choice for primary-care medicine.
Basis of Claim:
New Matter: "textual materials & artwork."
Previous Registration:
Product data prev. reg. 1979, TX 261-464.
Copyright Note:
C.O. correspondence.
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc.
In specific ventricular arrhythmias, right from the start, for hospitalized patients when oral medication is indicated, as initial therapy in most outpatients
Type of Work:
Print or label
Registration Number / Date:
TX0000844740 / 1981-11-09
Date of Publication:
July 9, 1979
Date of Creation:
1979
Title:
In specific ventricular arrhythmias, right from the start, for hospitalized patients when oral medication is indicated, as initial therapy in most outpatients.
Basis of Claim:
New Matter: "textual materials & artwork."
Previous Registration:
Product data prev. reg. 1979, TX 261-464.
Copyright Note:
C.O. correspondence.
Variant title:
In specific ventricular arrhythmias, right from the start, for hospitalized patients when oral medication is indicated
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
The New wave in cardiology
Type of Work:
Print or label
Registration Number / Date:
TX0000844741 / 1981-12-14
Date of Publication:
September 10, 1981
Date of Creation:
1981
Title:
The New wave in cardiology : favorable effects of Calan (verapamil HCl)
Basis of Claim:
New Matter: "textual materials & artwork."
Previous Registration:
Product data prev. reg. 1981, TX 793-798.
Copyright Note:
C.O. correspondence.
Copyright Claimant:
Searle Pharmaceuticals, Inc.
Names:
Searle Pharmaceuticals, Inc.
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible. Multiple persons can share the same name.